Teva Europe
Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by approximately 200 million patients in over 60 markets every day. Teva is the worldÕs largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has the world-leading innovative treatment for multiple sclerosis as well as late-stage development programs for other disorders of the central nervous system, including movement disorders, migraine, pain and neurodegenerative conditions, as well as a broad portfolio of respiratory products. Teva is leveraging its generics and specialty capabilities in order to seek new ways of addressing unmet patient needs by combining drug development with devices, services and technologies. Teva's net revenues in 2016 were $21.9 billion. For more information, visit www.tevapharm.com.
Pharmaceuticals
> 10,000
Petah Tikva, Israel
About

Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by approximately 200 million patients in over 60 markets every day.

Teva is the worldÕs largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has the world-leading innovative treatment for multiple sclerosis as well as late-stage development programs for other disorders of the central nervous system, including movement disorders, migraine, pain and neurodegenerative conditions, as well as a broad portfolio of respiratory products. Teva is leveraging its generics and specialty capabilities in order to seek new ways of addressing unmet patient needs by combining drug development with devices, services and technologies.

Teva's net revenues in 2016 were $21.9 billion. For more information, visit www.tevapharm.com.

Site Traffic
  • 480043 Global Rank
  • 252171
    United States
  • 114 K Estimated Visits
Traffic Sources
  • Search
    56.45%
  • Direct
    31.22%
  • Referrals
    11.76%
  • Social
    0.55%
  • Display
    0.01%
  • Mail
    0.00%
Geography Breakdown
Powered by
Alexa Traffic Data
Global Rank 194,570
308,669
India Rank 92,541
156
India Page Views 21.4%
2.7%
Top Countries
Top Search Keywords
  • Biotechnology and Pharmaceuticals
  • Pharmaceuticals
Mobile App Data
MixRank is the most comprehensive database of mobile apps, developers, SDKs, technologies, services, and integrations. Learn more.
  • 500 Downloads
  • 0 SDKs
  • 0 Total reviews
  • App Url: https://play.google.com/store/apps/details?id=com.tevapharm.digihaler.release
  • App Support: http://www.digihaler.com/support
  • Genre: medical
  • Bundle ID: com.tevapharm.digihaler.release
  • App Size: 69.5 M
  • Release Date: September 14th, 2020
  • Update Date: December 17th, 2020

Description:

Welcome to your Digihaler® app! See safety information below. This app
will help you keep track of your Digihaler events and tell you if your
inhaler technique may need improvement. You can also share reports from
the app with your doctor or others. When your Digihaler inhaler is
connected with your smartphone, data from your inhaler will be
transmitted to the app using Bluetooth wireless technology.
The Digihaler app can:
-Track your inhaler events and inspiratory flow rate
-Let you know if your inhaler technique may need improvement
-Let you know if you appear to be using your inhaler more, or less, than
recommended
-Remind you when a prescription refill might be needed
-Provide local forecasts for weather, air quality and pollen
-Create reports you can share
Indication and Important Safety Information for ProAir Digihaler
(albuterol sulphate):
ProAir Digihaler is a prescription medicine used to treat or prevent
bronchospasm in people ≥4 yrs who have reversible obstructive airway
disease and/or to prevent exercise-induced bronchospasm
-Do not use ProAir Digihaler if you are allergic to albuterol sulfate,
lactose, milk proteins, or any of the ingredients in ProAir Digihaler
-Call your healthcare provider right away if you have an allergic reaction
such as itchy bumps, throat swelling, rash or worsening of symptoms
including trouble breathing which could be life-threatening
-Using too much may be fatal. Do not take extra doses of ProAir Digihaler
without first talking to your doctor
-Talk to your doctor about your medical conditions and the medicines you
take
Other serious side effects include heart problems, low potassium and/or
higher blood sugar levels.
Talk to your doctor about other possible side effects. Please see full
Prescribing Information within this app or at www.Digihaler.com
Indication and Important Safety Information for AirDuo Digihaler
(fluticasone propionate/salmeterol):
AirDuo Digihaler is a combination of fluticasone propionate, a
corticosteroid, and salmeterol, a long-acting beta2-adrenergic agonist
(LABA), indicated for treatment of asthma in patients aged 12 years and
older.
-Do not use AirDuo Digihaler to treat sudden breathing problems from
asthma. Always have a rescue inhaler with you to treat sudden symptoms
-Do not use AirDuo Digihaler if you have a severe allergy to milk proteins
or if you are allergic to any of the ingredients in the product
-Do not take AirDuo Digihaler with other medicines that contain a LABA
for any reason
-Tell your healthcare provider about all the medicines you take and about
all of your health conditions
Other serious side effects include heart problems, serious allergic
reactions and/or changes in blood values.
Talk to your doctor about other possible side effects
Please see full Prescribing Information within this app or at
www.Digihaler.com
Indication and Important Safety Information for ArmonAir Digihaler
(fluticasone propionate):
ArmonAir Digihaler inhalation powder is a prescription inhaled
corticosteroid (ICS) medicine for the long-term treatment of asthma in
patients 12 years and older.
-Do not use ArmonAir Digihaler to treat sudden breathing problems from
asthma. Always have a rescue inhaler with you to treat sudden symptoms.
-Do not use ArmonAir Digihaler if you have a severe allergy to milk
proteins or if you are allergic to any of the ingredients in the product.
-Tell your healthcare provider about all the medicines you take and about
all of your health conditions.
-Do not stop using ArmonAir Digihaler, even if you are feeling better,
unless your healthcare provider tells you to. If you miss a dose of
ArmonAir Digihaler, just skip that dose. Take your next dose at your usual
time. Do not take 2 doses at 1 time.
Other serious side effects include heart problems, serious allergic
reactions and/or changes in blood values.
Talk to your doctor about other possible side effects
Please see full Prescribing Information within this app or at
www.Digihaler.com

Ad Intelligence
  • Standard
    0%
Ads Seen Recently
0
Longest Running Ad
Teva Europe
Device
Android
Dimensions
300x250
Teva Europe receives up to 0.1M pageviews per day, in countries such as United States.

They are headquartered at Petah Tikva, Israel, and have 1 advertising & marketing contacts listed on Kochava. Teva Europe works with Advertising technology companies such as DoubleClick.Net, LinkedIn Ads, Facebook Custom Audiences, Bizo, Google Remarketing, The Trade Desk, Google Floodlight Counter, DemDex, Adobe Audience Manager Sync, Yahoo Small Business, Advertising.com, AppNexus, Rubicon Project, BlueKai, BlueKai DMP.